UnitedHealth Group (UNH) Price Target Increased to $260.00 by Analysts at Deutsche Bank

UnitedHealth Group (NYSE:UNH) had its target price hoisted by Deutsche Bank to $260.00 in a research report report published on Wednesday. They currently have a buy rating on the healthcare conglomerate’s stock.

A number of other research analysts have also issued reports on the company. Citigroup lifted their target price on UnitedHealth Group from $235.00 to $268.00 and gave the stock a buy rating in a report on Wednesday. BMO Capital Markets lifted their target price on UnitedHealth Group from $14.50 to $275.00 and gave the stock an outperform rating in a report on Wednesday. Royal Bank of Canada lifted their target price on UnitedHealth Group from $269.00 to $280.00 and gave the stock an outperform rating in a report on Wednesday. Piper Jaffray Companies reaffirmed a buy rating and set a $259.00 target price on shares of UnitedHealth Group in a report on Wednesday. Finally, Cantor Fitzgerald reaffirmed a buy rating and set a $235.00 target price on shares of UnitedHealth Group in a report on Tuesday, January 16th. Two equities research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company’s stock. UnitedHealth Group has an average rating of Buy and an average price target of $243.22.

UnitedHealth Group (UNH) opened at $243.35 on Wednesday. The stock has a market capitalization of $235,822.70, a PE ratio of 24.14, a P/E/G ratio of 1.42 and a beta of 0.66. UnitedHealth Group has a fifty-two week low of $156.49 and a fifty-two week high of $244.35. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.58.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.50 by $0.09. The firm had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. UnitedHealth Group’s revenue was up 9.5% compared to the same quarter last year. During the same period in the previous year, the company earned $2.11 earnings per share. analysts anticipate that UnitedHealth Group will post 12.52 EPS for the current year.

In other UnitedHealth Group news, CEO Larry C. Renfro sold 22,598 shares of the firm’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the completion of the sale, the chief executive officer now directly owns 195,314 shares in the company, valued at approximately $43,310,879.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Gail R. Wilensky sold 5,600 shares of the firm’s stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total value of $1,250,536.00. Following the sale, the director now owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The disclosure for this sale can be found here. Insiders sold a total of 33,655 shares of company stock valued at $7,469,083 in the last quarter. 0.89% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently made changes to their positions in UNH. Blue Chip Partners Inc. acquired a new stake in UnitedHealth Group during the 2nd quarter worth about $110,000. Bruderman Asset Management LLC acquired a new stake in UnitedHealth Group during the 2nd quarter worth about $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its position in UnitedHealth Group by 433.3% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after acquiring an additional 520 shares during the period. BDO Wealth Advisors LLC acquired a new stake in UnitedHealth Group during the 2nd quarter worth about $121,000. Finally, Acrospire Investment Management LLC boosted its position in UnitedHealth Group by 130.7% during the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after acquiring an additional 400 shares during the period. Hedge funds and other institutional investors own 86.09% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was reported by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this news story on another domain, it was stolen and republished in violation of international copyright and trademark laws. The original version of this news story can be read at https://stocknewstimes.com/2018/01/21/unitedhealth-group-unh-price-target-increased-to-260-00-by-analysts-at-deutsche-bank.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply